A Pilot Study To Assess the Suitability of Riboflavin As a Surrogate Marker of Breast Cancer Resistance Protein in Healthy ParticipantsHong Shen, Michael Sinz, Yueping Zhang et al.|Journal of Pharmacology and Experimental Therapeutics|2024Cited by 15